Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026)
Roivant Sciences (ROIV) posted Other Non-Current Liabilities of $38.7 million for Q1 2026, up 5611.96% on a QoQ basis from $677000.0 in Q4 2025.
Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Roivant Sciences' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $38.7 million for Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $38.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.7 million (changed N/A YoY) and the FY2026 annual result came in at $38.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $38.7 million for Q1 2026 at Roivant Sciences, up from $677000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $38.7 million in Q1 2026 and bottomed at $170000.0 in Q3 2025.
- A 5-year average of $9.3 million and a median of $4.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 168.37% — and 2024, when it sank 94.3%.
- Roivant Sciences' Other Non-Current Liabilities stood at $21.5 million in 2022, then plunged by 79.38% to $4.4 million in 2023, then plunged by 93.07% to $307000.0 in 2024, then jumped by 120.52% to $677000.0 in 2025, then jumped by 5611.96% to $38.7 million in 2026.
- Business Quant data shows ROIV's Other Non-Current Liabilities at $38.7 million in Q1 2026, $677000.0 in Q4 2025, and $170000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.67 Mn |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 228,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 295,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 4.43 Mn |
| Sep 30, 2023 | 5.18 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 17.03 Mn |
| Dec 31, 2022 | 21.48 Mn |
| Sep 30, 2022 | 9.10 Mn |
| Jun 30, 2022 | 8.16 Mn |
| Mar 31, 2022 | 21.92 Mn |
| Dec 31, 2021 | 8.18 Mn |
| Sep 30, 2021 | 8.19 Mn |
| Jun 30, 2021 | 8.19 Mn |
| Mar 31, 2021 | 8.17 Mn |